Stay updated with breaking news from Translation Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists at University of Utah Health made a discovery that could lead to a new way to treat Parkinson's disease and potentially stop its progression.
E-Mail DALLAS, Feb. 10, 2021 — Reducing the prevalence of obesity may prevent up to half of new Type 2 diabetes cases in the United States, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association. Obesity is a major contributor to diabetes, and the new study suggests more tailored efforts are needed to reduce the incidence of obesity-related diabetes. Type 2 diabetes is the most common form of diabetes, affecting more than 31 million Americans, according to the U.S. Centers for Disease Control a...
E-Mail WINSTON-SALEM, N.C. - Jan. 11, 2021 - Most doctors would agree that advanced care planning (ACP) for patients, especially older adults, is important in providing the best and most appropriate health care over the course of a patient's life. Unfortunately, the subject seldom comes up during regular clinic visits. In a study conducted by doctors at Wake Forest Baptist Health, only 3.7% of primary care physicians had this conversation with their patients as part of their normal care. Yet in the same study, the researchers found that a new approach involving specially trained nurses su...
Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.
Expert panel votes FDA SHOULD give Moderna's COVID-19 vaccine emergency approval amid hopes the U.S will soon have a second shot to help get 20 million Americans vaccinated by the end of 2020 A panel of FDA experts voted that the agency should approve Moderna's coronavirus vaccine and recommend whether the shot should be approved With their endorsement, Moderna's shot will almost certainly get emergency approval tonight or tomorrow Two people in Moderna's trial had severe allergic reactions: one who got a placebo, and a vaccine recipient who had anaphylactic shock 63 days later Modern...